Let's Talk About SACT

Disclaimer: The views and opinions expressed during this episode are those of the individual speakers and are shared in their personal capacity. They do not necessarily reflect the views, positions, or policies of the companies with which the speakers are affiliated. In this episode we are joined by Poonam Dhokia, Dolapo Sanni and Zsofia Nemeth. We explore the pharmaceutical industry from the pers...

In this episode we are joined by Nikita Ponda. We discuss the pharmacist role in a melanoma charity, we discuss TrialFinder, developments in melanoma and much more.

In this episode we are joined by Dani Binnington, founder of Menopause and Cancer (https://menopauseandcancer.org/). We discuss Dani's journey as a cancer patient going through menopause, guidance and best practice. Link for Non-hormonal-based treatments for menopausal symptoms guidance: https://thebms.org.uk/wp-content/uploads/2025/11/04-BMS-ConsensusStatement-Non-hormonal-based-treatments-for-me...

In this episode we are joined by Alice Tew and Meera Desai. We discuss the history of the immunotherapy group, how and why it was established and how its work has evolved. We explore key projects including improving equity of access to second-line agents, the development of immunotherapy monographs, upcoming priorities for the group and much more.

In this episode we are joined by Alia Nizam. We discuss the Cancer Research UK Consent Form Project. We explore how and why the project was developed, what's involved in creating consent forms and much more.

In this episode we are joined by Andrew Hantel, Stephen Hibbs and Lauren Merz. We discuss the Duffy Null variant. Specifically what it is, the history, clinical impact and much more.

In this episode we are joined by Hana, also known as @pharmadrama on Instagram. Hana is a hospital pharmacist based in the UK who creates content about pharmacy practice, especially in the field of cancer care. We discuss online cancer misinformation, how to tackle it and much more.

In this episode we are joined by Suzanne Frank. We discuss Inavo120 (Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer) study. We discuss the relevance of the data and how it might change practice going forward. This study is available to read at https://www.nejm.org/doi/full/10.1056/NEJMoa2404625 and the update at https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.1003

In this episode we are joined by Benjamin Dowsing. We discuss what cardio-oncology is, baseline monitoring, managing patients who develop cardiotoxicity, long term cardiac follow-up and much more.

In this episode we are joined by Bhumik Patel. We discuss what a paediatric palliative care pharmacist does, common symptoms experienced by patients in paediatric palliative care, managing complex polypharmacy in the very young, challenges around unlicensed and off label medication use and much more.

In this episode we are joined by Emma Williams . We discuss what virtual assessment pathway clinics are, how they were set up at Velindre Cancer Centre, feedback, and much more.

In this episode we are joined by Ben Nelson. We discuss a paper titled “Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer”. This paper is available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10171177/

In this episode we are joined by Julian Barwell. We discuss predictions for what 21st century healthcare is going to look like, what will doctors be doing and how we can train them, balancing digital and molecular progress and much more.

In this episode we are joined by Chiara Creed, Shumi Tattersfield and Jane Neerkin. We discuss what elastomeric pumps are, clinical applications, advantages and much more.

In this episode we are joined by Caroline Wilson and Alison Taylor. We discuss what acute oncology services are and why they are crucial, how cancer patients are supported, common emergencies and much more.

In this episode we are joined by Naima Fowlis. We discuss having difficult conversations with patients and staff. We cover the process of breaking bad news, supporting emotional reactions, balancing professionalism and compassion, team dynamics and much more.

In this episode we are joined by Chris Salmen. We discuss what DLBCL is, diagnosis, management and much more.

In this episode we are joined by Apini Patel. We discuss what hyperthermic intraperitoneal chemotherapy (HIPEC) is and how it’s used as a cancer treatment, administration of HIPEC, supporting patients undergoing HIPEC and much more.

In this episode we are joined by Robin Woolcock. We discuss Robin's experience with TNBC, the reason for setting up The UK Charity for TNBC, available support for patients and staff and much more. To access the website click the following link: https://www.ukcharityfortnbc.org/

In this episode we are joined by Alison Berner. We discuss available resources to better support transgender patients, special considerations, creating supportive and inclusive environments and much more.

In this episode we are joined by Pinkie Chambers. We discuss her current research project, the role of a pharmacist as a principal investigator and getting involved in research.

In this episode we are joined by Nusrat Latif. We discuss the British Asian Cancer Charity, current initiatives at tackling inequalities, current projects, campaigns and much more.

In this episode we are joined by the BOPA chair, Joe Williams. We discuss changes in the executive committee, plans for BOPA in 2024 and reflect on the past year.

In this episode we are joined by Helen Thompson. We discuss the Cancer Research UK (CRUK) Charity. We discuss key features of the CRUK website, unique resources, how CRUK can support patients and healthcare staff as well as other topics.

In this episode we are joined by Chris Salmen. We discuss high dose methotrexate . We delve into pharmacokinetics, toxicities, monitoring requirements and Chris' experience.